When clinical trials fail to address treatment gaps: the failure of niacin-laropiprant to reduce cardiovascular events
- PMID: 23605289
- DOI: 10.1007/s11883-013-0332-x
When clinical trials fail to address treatment gaps: the failure of niacin-laropiprant to reduce cardiovascular events
Comment on
-
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.Eur Heart J. 2013 May;34(17):1279-91. doi: 10.1093/eurheartj/eht055. Epub 2013 Feb 26. Eur Heart J. 2013. PMID: 23444397 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical